Advances in Omics Technologies for Precision Medicine in Kidney Diseases
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Omics/Informatics".
Deadline for manuscript submissions: 20 June 2025 | Viewed by 520
Special Issue Editor
Interests: biochemistry; biomarkers; hypertension; cardiovascular disease; kidney disease
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Recent advances in omics technologies, such as genomics, proteomics, metabolomics, and transcriptomics, have significantly enhanced our understanding of kidney diseases at a molecular level. These high-throughput techniques provide a comprehensive view of the biological processes involved in kidney pathophysiology, facilitating the identification of novel biomarkers and therapeutic targets. In precision medicine, omics approaches offer personalized insights into disease mechanisms, enabling tailored treatments that improve patient outcomes. This Special Issue aims to highlight cutting-edge research and emerging technologies in the field of omics and their application to precision medicine for kidney diseases. We welcome contributions that explore innovative methodologies, data integration strategies, and the translation of omics findings into clinical practice, ultimately advancing our ability to diagnose, monitor, and treat kidney disorders with a precision medicine approach.
Prof. Dr. Marijn Speeckaert
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- precision medicine
- omics technologies
- kidney diseases
- genomics
- proteomics
- metabolomics
- transcriptomics
- biomarkers
- molecular pathophysiology
- data integration
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
